The researchers reviewed major studies of both PrEP for HIV prevention and aspirin for heart attack prevention. They found that both had similar low rates of serious side effects. Aspirin users rarely ...

What is Pre-Exposure Prophylaxis (PrEP)? Pre-Exposure Prophylaxis (PrEP) is an HIV prevention strategy that enables HIV-negative people to stay HIV-negative by taking anti-HIV drugs (also called ...

LA CAB for PrEP shows high effectiveness and persistence among Black cisgender and transgender women in the United States.

HIV-1 infection remains a major public health problem, with an estimated 38.4 million people living with HIV and 1.5 million new HIV infections reported worldwide in 2021. The risk of HIV infection ...

CDC: New HIV Pre-Exposure Prophylaxis Guidelines New clinical guidelines on HIV pre-exposure prophylaxis (PrEP) recommend the use of anti-HIV drugs by uninfected patients who are at substantial risk ...

Executive actions in 2025 produced a 90-day freeze and stop orders; waivers incompletely restored services, with notable gaps in PrEP access for nonpregnant, nonbreastfeeding individuals. New research ...

Pre-exposure prophylaxis (PrEP) is a drug regimen recommended for anyone at high risk of getting HIV to prevent them from being infected. Little research exists on how state-level policies might be ...

A new HIV antiretroviral shows promise as a long-acting, oral prophylactic agent, according to a new study by Izzat Raheem, Tracy Diamond and colleagues from Merck & Co., Inc., Rahway, NJ, USA, ...

The Global Fund has committed an additional Sh256 million($2 million) to support Kenya’s rollout of the long-acting HIV preventioninjection, Lenacapavir, officials announced during the national launch ...

What follows is an update to the New York State Department of Health guidelines on HIV Prophylaxis Following Non-occupational Exposure (nPEP). While avoidance of exposure to HIV remains the best way ...